Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer
Active, not recruiting · NCT03949283 · Registry updated 2024-08-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Cancer Stem Cell Assay Directed Chemotherapy in Recurrent Platinum Resistant Ovarian Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Active, not recruiting | Phase 3 | 2024-08-22 | NCT03949283 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cordgenics, LLC | 1 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Charleston Area Medical Center (CAMC) | Charleston | United States | 2 |
| Edwards Comprehensive Cancer Center - Cabell Huntington Hospital | Huntington | United States | 1 |
| Kaiser Permanente | Los Angeles | United States | 9 |
| LSU Health Sciences Center | New Orleans | United States | 3 |
| Miami Cancer Institute/Baptist Health South Florida | Miami | United States | 1 |
| University of Cincinnati Cancer Institute | Cincinnati | United States | 1 |
| University of Oklahoma Health Sciences Center | Oklahoma City | United States | 491 |
| West Penn Hospital, Allegheny Health Network | Pittsburgh | United States | 1 |